ANDA 64076, held by Sandoz. Amoxicillin.
As of Nov 14, 2026, ANDA 64076 (Amoxicillin), held by Sandoz, was first approved by FDA on Sep 30, 1994, with 19 approved supplements and 0 published complete response letters.
Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae. Infections of the Genitourinary Tract Amoxicillin is
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 1994 | Original application | Approved | None posted |
| Amoxicillin250MG · capsule;oral | Amoxicillin | Rx |
| Amoxicillin500MG · capsule;oral | Amoxicillin | Rx |
| May 1, 2024 | Supplement 38Labeling · Standard review | Approved | None posted |
| Apr 25, 2024 | Supplement 37Labeling · Standard review | Approved | None posted |
| Jun 3, 2020 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jun 3, 2020 | Supplement 30Labeling · Standard review | Approved | None posted |
| Nov 25, 2014 | Supplement 27Labeling · Standard review | Approved | None posted |
| Feb 22, 2013 | Supplement 25Labeling · Standard review | Approved | None posted |
| May 31, 2007 | Supplement 18Labeling | Approved | None posted |
| May 31, 2007 | Supplement 17Labeling | Approved | None posted |
| May 10, 2006 | Supplement 16Labeling | Approved | None posted |
| Sep 9, 2005 | Supplement 14Labeling | Approved | None posted |
| Sep 30, 2004 | Supplement 12Labeling | Approved | None posted |
| Sep 30, 2004 | Supplement 11Labeling | Approved | None posted |
| Apr 6, 2004 | Supplement 10Labeling | Approved | None posted |
| Apr 12, 2001 | Supplement 7Manufacturing | Approved | None posted |
| Dec 21, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Aug 7, 2000 | Supplement 5Manufacturing | Approved | None posted |
| Apr 14, 1997 | Supplement 4Manufacturing | Approved | None posted |
| Nov 8, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Nov 8, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Sep 30, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters